Two new cyclotetrapeptides, sartoryglabramides A (
5) and B (
6), and a new analog of fellutanine A (
8) were isolated, together with six known compounds including ergosta-4, 6, 8 (14), 22-tetraen-3-one, ergosterol 5, 8-endoperoxide, helvolic acid, aszonalenin (
[...] Read more.
Two new cyclotetrapeptides, sartoryglabramides A (
5) and B (
6), and a new analog of fellutanine A (
8) were isolated, together with six known compounds including ergosta-4, 6, 8 (14), 22-tetraen-3-one, ergosterol 5, 8-endoperoxide, helvolic acid, aszonalenin (
1), (3
R)-3-(1
H-indol-3-ylmethyl)-3,4-dihydro-1
H-1,4-benzodiazepine-2,5-dione (
2), takakiamide (
3), (11a
R)-2,3-dihydro-1
H-pyrrolo[2,1-
c][1,4]benzodiazepine-5,11(10
H,11a
H)-dione (
4), and fellutanine A (
7), from the ethyl acetate extract of the culture of the marine sponge-associated fungus
Neosartorya glabra KUFA 0702. The structures of the new compounds were established based on extensive 1D and 2D spectral analysis. X-ray analysis was also used to confirm the relative configuration of the amino acid constituents of sartoryglabramide A (
5), and the absolute stereochemistry of the amino acid constituents of sartoryglabramide A (
5) and sartoryglabramides B (
6) was determined by chiral HPLC analysis of their hydrolysates by co-injection with the
d- and
l- amino acids standards. Compounds
1–
8 were tested for their antibacterial activity against Gram-positive (
Escherichia coli ATCC 25922) and Gram-negative (
Staphyllococus aureus ATCC 25923) bacteria, as well as for their antifungal activity against filamentous (
Aspergillus fumigatus ATCC 46645), dermatophyte (
Trichophyton rubrum ATCC FF5) and yeast (
Candida albicans ATCC 10231). None of the tested compounds exhibited either antibacterial (MIC > 256 μg/mL) or antifungal activities (MIC > 512 μg/mL).
Full article